Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

pathology market

New Cytology Technology Entering Study Phase

CEO SUMMARY: There’s a new contestant in the ongoing battle to win the Pap smear technology wars. Ampersand Medical Corporation, by signing a strategic alliance with AmeriPath, Inc., has signaled that it’s ready to bring its technology to market. AmeriPath will play a major role in ex…

Read More



“Local” Anatomic Path Has Two Major Players

CEO SUMMARY: After a lot of money and much effort, the fledgling crop of companies wanting to consolidate and manage pathology group practices has narrowed into just two market leaders: AmeriPath and Pathology Service Associates. These two companies could not be more different in their go…

Read More



Lab Sales & Marketing Programs Are Changing

CEO SUMMARY: Market evidence points to a shifting role in the sales priorities of the national labs. Meanwhile, regional laboratories and pathology companies are enjoying surprising success with their sales and marketing programs. These shifting patterns may indicate a new stratification …

Read More



Competitive Dynamics In the Laboratory Testing Marketplace

This section of the White Paper deals with the marketplace for laboratory services. For brevity and clarity, I will address five components: 1) independent commercial laboratories; 2) hospital-based laboratories; 3) esoteric, reference, and specialty testing laboratories; 4) anatomic pathology lab- o…

Read More



AmeriPath Will Acquire Inform DX for $44.6 Mil

CEO SUMMARY: It’s another example of consolidation in the anatomic pathology marketplace. AmeriPath, Inc.’s acquisition of Inform DX, Inc. positions the company to do as much as $350 million in revenues next year. By acquiring Inform DX, AmeriPath also gains entry into six more states…

Read More



AmeriPath & InformDX Merging To Form Largest Anatomic Pathology Firm in U.S.

CEO SUMMARY: AmeriPath and InformDX shared several common elements in their respective business strategies. Both companies believe that pathology services are best delivered at the local level and benefit from the support of a national organization. Both companies believe that physicians …

Read More



AmeriPath Pursues Ambitious Strategy Of Rapid Expansion

CEO SUMMARY: As the pathology profession’s only publicly-traded physician practice management company, AmeriPath is the spear point of far-reaching changes now transforming pathology. With an annual revenue run rate of $270 million and an ample war chest of growth capital, AmeriPath int…

Read More



Single-Specialty Path PPMs Posting Strong Growth, Profits

CEO SUMMARY: Although the financial travails of the physician practice management (PPM) industry are widely known, there is little recognition that a number of single-specialty PPMs are doing well. This is true of pathology, where at least six pathology-based PPMs still remain in business…

Read More



Don’t Take Your Eyes Off the Ball!

HOW MANY OF US HAD A FATHER WHO TAUGHT US THE BASICS OF BASEBALL almost as soon as we learned to walk? I can still remember my father repeatedly advising me “don’t take your eyes off the ball!” With the recent merger of Quest Diagnostics Incorporated and SmithKline Bee…

Read More



Associated Pathologists Laboratories, Dynacare, Bio-Reference Labs, Quest, AmeriPath

ASSOCIATED PATH LABS WINS PATENT FOR DRUGS OF ABUSE TEST IT’S NOT TOO OFTEN that independent commercial laboratories are awarded patents. Las Vegas-based Associated Pathologists Laboratories received a patent for a technique it developed relating to drugs of abuse testing….

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;